EURneffy 1 mg will be the first and only needle-free adrenaline available to younger children in the European UnionARS Pharma’s partner, ...

ALK has announced that its EURneffy 1mg nasal adrenaline spray has received a positive opinion from the Committee for ...

BOSTON (Oct. 24, 2024) – Anaphylaxis can come on suddenly and without warning, and because its symptoms can be fatal, it is scary for those who encounter it. Two new studies being presented at this ...

A new epinephrine nasal spray is huge news for Blacks, who suffer from higher rates of severe, life-threatening food allergies. The Food and Drug Administration has just approved a first-of-its-kind ...

An international panel of experts has developed standardized definitions and treatment protocols for anaphylaxis, aiming to eliminate long-standing inconsistencies in emergency care. The Global ...

Misinformation and outdated protocols contribute to the suboptimal management of anaphylaxis by patients and healthcare professionals, based on data from two new studies presented at the American ...

Good news for those who suffer from severe allergic reactions: a nasal spray containing epinephrine rather than a needle can now treat those frightening moments. The treatment, called Neffy, was ...

A groundbreaking consensus report on anaphylaxis – the severe reaction some people experience from bee stings, peanut butter exposures, medications, and the like – has been released by the Global ...

The positive CHMP opinion supports an extension to the existing marketing authorisation for EUR neffy ® 2 mg granted by the European Commission (‘EC’) in August 2024 for the emergency treatment of ...

“Outdated protocols” and a lack of patient education around anaphylaxis treatment can result in poor patient outcomes, Medscape Medical News reported Oct. 28. A survey of 96 patients and caregivers ...

Feb 2 (Reuters) - Aquestive Therapeutics said on Monday the U.S. Food and Drug administration has declined to approve its ...

In a second warning letter, the agency calls out what it says are misleading claims and images in the nasal anaphylaxis ...